Physician

Derek Peter Kuhl, MD, PHD

According to 2025 Medicare claims, Derek Kuhl, MD, PHD (NPI: 1629074844) practices ophthalmology in the College Station-Bryan, TX market, with the plurality of this provider's patient population coming from Brazos, TX. This provider's primary affiliated billing organization is RETINA CENTER P A (NPI: 1922006246; TIN: 200872732) and primary practice location at 77802-2601.

Kuhl's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 794 traditional Medicare patients, billed 12,958 HCPCS/CPT codes, and received $1,313,909 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 1,170 prescription claims across 288 beneficiaries totaling $135,248 in drug costs, led by Cyclosporine (Cyclosporine). Open Payments data shows 9 records totaling $212. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $2,523,193 to $1,313,909. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.7M2015 Medicare payment: $2,523,193 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,353,842 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,456,720 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,678,829 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,328,830 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,656,532 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,650,989 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,694,212 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,667,039 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,313,909 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,60321,580$2,523,193
20161,52119,386$2,353,842
20171,47620,418$2,456,720
20181,52722,165$2,678,829
20191,30719,152$2,328,830
202089513,966$1,656,532
202187613,875$1,650,989
202295914,534$1,694,212
202399415,143$1,667,039
202479412,958$1,313,909

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$101K$202K2015 Drug cost: $149,224 (USD; Tot_Drug_Cst)2016 Drug cost: $130,387 (USD; Tot_Drug_Cst)2017 Drug cost: $155,099 (USD; Tot_Drug_Cst)2018 Drug cost: $167,935 (USD; Tot_Drug_Cst)2019 Drug cost: $201,885 (USD; Tot_Drug_Cst)2020 Drug cost: $145,291 (USD; Tot_Drug_Cst)2021 Drug cost: $135,418 (USD; Tot_Drug_Cst)2022 Drug cost: $141,390 (USD; Tot_Drug_Cst)2023 Drug cost: $145,798 (USD; Tot_Drug_Cst)2024 Drug cost: $135,248 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152751,240$149,224
20162631,209$130,387
20172741,342$155,099
20182661,277$167,935
20193171,432$201,885
20202551,068$145,291
20212341,008$135,418
20222501,043$141,390
20232691,069$145,798
20242881,170$135,248

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system178178$98
92014Established patient complete exam of visual system6762,354$91
67028Injection of drug into eye3282,188$87
J7999Compounded drug, not otherwise classified2221,354$66
92134Imaging of retina7492,558$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CyclosporineCyclosporine412,235$19,827
ProlensaBromfenac Sodium361,525$15,670
MieboPerfluorohexyloctane/Pf15705$13,563
Bromfenac SodiumBromfenac Sodium652,560$12,675
Prednisolone AcetatePrednisolone Acetate1949,971$10,423

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$212ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Derek Peter Kuhl, MD, PHD?

Tedicare shows public-source Medicare data for Derek Peter Kuhl, MD, PHD (NPI 1629074844), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Derek Peter Kuhl, MD, PHD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Derek Peter Kuhl, MD, PHD?

Derek Peter Kuhl, MD, PHD is linked to RETINA CENTER P A (billing NPI 1922006246) in the available physician profile data.

Does Derek Peter Kuhl, MD, PHD have Open Payments data?

Derek Peter Kuhl, MD, PHD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.